Levodopa impairs learning in healthy young adults: Implications for Parkinson's disease

被引:0
|
作者
MacDonald, P. A.
Vo, A.
Seergobin, K. N.
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
1356
引用
收藏
页码:S445 / S445
页数:1
相关论文
共 50 条
  • [1] Levodopa impairs probabilistic reversal learning in healthy young adults
    Vo, Andrew
    Seergobin, Ken N.
    Morrow, Sarah A.
    MacDonald, Penny A.
    PSYCHOPHARMACOLOGY, 2016, 233 (14) : 2753 - 2763
  • [2] Levodopa impairs probabilistic reversal learning in healthy young adults
    Andrew Vo
    Ken N. Seergobin
    Sarah A. Morrow
    Penny A. MacDonald
    Psychopharmacology, 2016, 233 : 2753 - 2763
  • [3] Levodopa enhances reward learning but impairs reversal learning in Parkinson's disease patients
    Moustafa, Ahmed A.
    FRONTIERS IN HUMAN NEUROSCIENCE, 2011, 4
  • [4] Levodopa suppresses grid-like activity and impairs spatial learning in novel environments in healthy young adults
    Goenner, Lorenz
    Baeuchl, Christian
    Gloeckner, Franka
    Riedel, Philipp
    Smolka, Michael N.
    Li, Shu-Chen
    CEREBRAL CORTEX, 2023, 33 (23) : 11247 - 11256
  • [5] Levodopa impairs baroreflex adjustment of circulatory homeostasis in Parkinson's Disease
    Rumbach, L
    Bouhaddi, M
    Vuillier, F
    Sablot, D
    Capelle, S
    Chavot, D
    Henriet, MT
    Moulin, T
    Regnard, J
    NEUROLOGY, 2001, 56 (08) : A347 - A347
  • [6] α-Synuclein impairs macroautophagy: implications for Parkinson's disease
    Winslow, Ashley R.
    Chen, Chien-Wen
    Corrochano, Silvia
    Acevedo-Arozena, Abraham
    Gordon, David E.
    Peden, Andrew A.
    Lichtenberg, Maike
    Menzies, Fiona M.
    Ravikumar, Brinda
    Imarisio, Sara
    Brown, Steve
    O'Kane, Cahir J.
    Rubinsztein, David C.
    JOURNAL OF CELL BIOLOGY, 2010, 190 (06): : 1023 - 1037
  • [7] Pramipexole Impairs Stimulus-Response Learning in Healthy Young Adults
    Gallant, Haley
    Vo, Andrew
    Seergobin, Ken N.
    MacDonald, Penny A.
    FRONTIERS IN NEUROSCIENCE, 2016, 10
  • [8] Can there be learning potential in Parkinson's disease? A comparison with healthy older adults
    Sales, A.
    Pitarque, A.
    Escudero, J.
    Satorres, E.
    Melendez, J. C.
    DEVELOPMENTAL NEUROPSYCHOLOGY, 2017, 42 (7-8) : 460 - 469
  • [9] Pharmacokinetics of levodopa/benserazide versus levodopa/carbidopa in healthy subjects and patients with Parkinson's disease
    Iwaki, Hirotaka
    Nishikawa, Noriko
    Nagai, Masahiro
    Tsujii, Tomoaki
    Yabe, Hayato
    Kubo, Madoka
    Ieiri, Ichiro
    Nomoto, Masahiro
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2015, 3 (02): : 68 - 73
  • [10] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188